Ami Organics Ltd

Acutaas Chemicals Ltd announces that Acutaas Chemicals Electrolytes Private Limited (ACEPL) is no longer a wholly-owned subsidiary, effective May 19, 2026. This follows the allotment of 1,111 equity shares to A.R.Z Pharma Ltd, reducing Acutaas Chemicals' stake in ACEPL from 100% to 90%. The dilution does not affect management control, with ACEPL remaining under Acutaas Chemicals' management. The equity shares were issued at ₹52,490 per share, including a premium of ₹52,480.

Acutaas Chemicals Ltd.'s Board of Directors, at their meeting on April 30, 2026, has recommended a final dividend of ₹2.50 per equity share for the financial year 2025-26. This dividend, representing 50% of the face value of ₹5 per share, is subject to approval by shareholders at the forthcoming 19th Annual General Meeting. The recommendation applies to 8,18,71,122 fully paid-up equity shares. The company will announce the record date, book closure dates, and dividend payout date in due course.

Acutaas Chemicals Limited reported strong financial results for Q4 and the full year ended March 31, 2026. For Q4 FY26, revenue from operations grew 40.3% year-on-year to ₹4,328 million, and Profit After Tax (PAT) increased 114.1% year-on-year to ₹1,343 million, achieving its highest ever PAT margin of 31.0%. For the full year FY26, revenue from operations rose 33.0% to ₹13,394 million, with PAT surging 122.2% to ₹3,564 million. Executive Chairman & MD, Mr. Naresh Patel, highlighted the company's strategy to diversify into Battery Chemicals, Semiconductors, and Pharmaceutical CDMO, expressing confidence in delivering 25% revenue growth in FY27.

Acutaas Chemicals Ltd's Board of Directors, at their meeting on April 30, 2026, approved the audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026. The Board also recommended a final dividend of ₹2.5 per equity share (50% on ₹5 face value) for FY 2025-26, pending shareholder confirmation at the upcoming AGM. Additionally, M/s Chirag Vallabhbhai Vekariya & Co. was appointed as Cost Auditors and M/s K. C Mehta & Co. LLP. as Internal Auditors for FY 2026-27. Indichem INC was identified as a Material Subsidiary.

Acutaas Chemicals Ltd's Board of Directors, at its meeting on April 30, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board also recommended a final dividend of ₹2.50 per equity share (50% on ₹5 face value) for FY 2025-26, subject to shareholder confirmation. Additionally, M/s Chirag Vallabhbhai Vekariya & Co. was appointed as Cost Auditors and M/s K. C Mehta & Co. LLP as Internal Auditors for FY 2026-27. Indichem INC was identified as a Material Subsidiary.

Acutaas Chemicals Ltd has scheduled a Board of Directors meeting on April 30, 2026, to consider the recommendation of a final dividend for the financial year 2025-26. The dividend, if recommended, will be subject to the approval of the members at the Annual General Meeting. The trading window for dealing in the company's shares has been closed from April 1, 2026, and will reopen on May 4, 2026.

Acutaas Chemicals Ltd has scheduled a Board of Directors meeting on April 30, 2026, to consider and approve the audited standalone and consolidated financial statements and results for the fourth quarter and financial year ended March 31, 2026. The board will also consider recommending a final dividend for FY 2025-26. The trading window remains closed until May 2, 2026, reopening on May 4, 2026.

Acutaas Chemicals Ltd has announced the closure of its trading window for all designated persons, including their immediate relatives and specified connected persons. The closure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's own Code of Conduct. The closure will be effective from Wednesday, April 1, 2026, for the purpose of considering the audited financial results for the fourth quarter and year ending on March 31, 2026. The trading window will reopen 48 hours after the declaration of the audited financial results.

Acutaas Chemicals Ltd's wholly owned subsidiary, Acutaas Advance Material Limited, has completed the acquisition of a 75% stake in Indichem Inc, a South Korean company in the semiconductor chemicals industry. This acquisition is in line with Acutaas' growth strategy, complementing its existing product portfolio. The transaction was completed through cash consideration via banking channels. Indichem Inc is a newly incorporated company in 2025, and the acquisition cost was 300,000 shares at a par value of KRW 500 plus share premium.

Acutaas Chemicals Ltd has released the recording of its Earnings Call held on January 28, 2026. The recording is available on the company's website and can be accessed using the provided link. This disclosure is in accordance with Regulation 30 and 46(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.